AR112775A1 - Detección directa de mecanismos de resistencia por espectrometría de masa maldi-tof - Google Patents
Detección directa de mecanismos de resistencia por espectrometría de masa maldi-tofInfo
- Publication number
- AR112775A1 AR112775A1 ARP180102199A ARP180102199A AR112775A1 AR 112775 A1 AR112775 A1 AR 112775A1 AR P180102199 A ARP180102199 A AR P180102199A AR P180102199 A ARP180102199 A AR P180102199A AR 112775 A1 AR112775 A1 AR 112775A1
- Authority
- AR
- Argentina
- Prior art keywords
- maldi
- mass spectrometry
- resistance mechanisms
- direct detection
- tof mass
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title abstract 3
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 4
- 238000001228 spectrum Methods 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000004590 computer program Methods 0.000 abstract 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 abstract 1
- 230000008261 resistance mechanism Effects 0.000 abstract 1
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 abstract 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Un método para la detección directa de mecanismos de resistencia mediante Espectrometría de masas MALDI-TOF. El método comprende preparar diferentes cultivos bacterianos y además utilizar una técnica de ácido sinapínico para la detección de proteína intacta, en donde cada cultivo bacteriano está contenido en una mancha objetivo MALDI. El método también comprende adquirir un espectro de cada cultivo estableciendo el rango de espectro de un espectrómetro de masas, usando un programa de computación para MALDI-TOF, a un rango comprendido entre 17.000 y 50.000 Da. Finalmente, se comparan los diferentes espectros adquiridos teniendo en cuenta un peso teórico de la proteína a detectar.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762547001P | 2017-08-17 | 2017-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR112775A1 true AR112775A1 (es) | 2019-12-11 |
Family
ID=63452598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180102199A AR112775A1 (es) | 2017-08-17 | 2018-08-02 | Detección directa de mecanismos de resistencia por espectrometría de masa maldi-tof |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR112775A1 (es) |
| WO (1) | WO2019034437A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102729119B1 (ko) * | 2019-08-02 | 2024-11-13 | (재)씨젠의료재단 | 베타-락탐 항생제에 대한 내성을 가지는 병원성 균주의 직접 검출 방법 |
| WO2021137645A1 (ko) * | 2019-12-30 | 2021-07-08 | (재)씨젠의료재단 | 카바페넴 항생제에 대한 내성을 가지는 병원성 균주의 직접 검출 방법 |
| WO2021263123A1 (en) * | 2020-06-26 | 2021-12-30 | Thermo Fisher Scientific Oy | Rapid mass spectrometric methods for identifying microbes and antibiotic resistance proteins |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9874570B2 (en) | 2011-04-21 | 2018-01-23 | Biomerieux, Inc. | Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry |
| CA2833454C (en) | 2011-04-21 | 2020-03-10 | Biomerieux Inc. | Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry |
| EP2867377B1 (en) | 2012-07-02 | 2019-08-21 | The Translational Genomics Research Institute | Primers, assays and methods for detecting an e. coli subtype |
| US9618510B2 (en) | 2013-03-13 | 2017-04-11 | Meso Scale Technologies, Llc. | Assay methods |
| CZ2013473A3 (cs) * | 2013-06-20 | 2014-11-26 | Univerzita Karlova v Praze, Lékařská fakulta v Plzni | Způsob detekce beta-laktamáz gramnegativních bakterií hmotnostní spektrometrií |
| FR3024465B1 (fr) | 2014-07-30 | 2018-03-23 | Biomerieux | Caracterisation de micro-organismes par maldi-tof |
| EP3449010A1 (en) | 2016-04-27 | 2019-03-06 | The Secretary of State for Health | Method for detecting carbapenemase-producing bacteria |
| AU2017288944B2 (en) | 2016-06-27 | 2023-10-26 | Becton, Dickinson And Company | Compositions, methods, systems and/or kits for detecting antimicrobial resistance in bacteria |
| KR101850854B1 (ko) | 2016-10-17 | 2018-04-20 | 연세대학교 원주산학협력단 | 퀀타매트릭스 어세이 플랫폼 기반 그람양성, 그람음성균 및 캔디다의 검출 및 동정과 항생제 내성여부를 동시 확인할 수 있는 진단법 및 그 키트 |
-
2018
- 2018-08-02 AR ARP180102199A patent/AR112775A1/es unknown
- 2018-08-02 WO PCT/EP2018/070965 patent/WO2019034437A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019034437A1 (en) | 2019-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2024002249A1 (es) | Muteína de il-21; conjugado; método de producción; composición farmacéutica; y su uso. | |
| MX2020012765A (es) | Métodos y compuestos de ácido nucleico modificado con lípidos. | |
| AR112775A1 (es) | Detección directa de mecanismos de resistencia por espectrometría de masa maldi-tof | |
| BR112015031639A2 (pt) | integração alvo | |
| BR112017014269A2 (pt) | células exterminadoras naturais e usos das mesmas | |
| WO2019126634A3 (en) | Targeted integration of nucleic acids | |
| MX383709B (es) | Microbios, composiciones y consorcios microbianos beneficiosos para la agricultura. | |
| EP4219744A3 (en) | Methods of preparing nucleic acids for sequencing | |
| CR20180525A (es) | Producción de ácido ribonucleico libre de células | |
| BR112013000822A2 (pt) | método e método de duas etapas para a produção de uma população de células exterminadoras naturais (nk) ativadas, população de células nk ativadas e método para suprimir a proliferação de células tumorais | |
| BR112015021993A8 (pt) | polipeptídeo, métodos para sua produção, métodos para cultivo de uma célula, composição farmacêutica, kit, e meio de cultura celular | |
| EP4372090A3 (en) | Crispr-related methods and compositions with governing grnas | |
| WO2016061286A3 (en) | Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same | |
| BR112018007538A2 (pt) | células exterminadoras naturais e células ilc3 e usos das mesmas | |
| MX2017008817A (es) | Composiciones y metodos para la glicosilacion de proteinas. | |
| BR112019008385A2 (pt) | método de preparação de células de levedura eletrocompetentes e métodos de uso das referidas células | |
| MX2022003039A (es) | Metodo de seleccion de donantes universales para identificar donantes de celulas nk. | |
| Tesei et al. | Proteome of tolerance fine-tuning in the human pathogen black yeast Exophiala dermatitidis | |
| BR112017001696A2 (pt) | composições de célula-tronco e métodos de produção de células-tronco para aplicações terapêuticas | |
| BR112018016133A2 (pt) | aglutinantes de max como moduladores de myc e usos dos mesmos | |
| JP2017525971A5 (es) | ||
| WO2015076717A3 (en) | Mscs in the treatment of cardiac disorders | |
| CO6592086A2 (es) | Metodo para producir proteinas de interferon recombiantes solubles sin desnaturalizacion | |
| EA201891747A1 (ru) | Полинуклеотиды и полипептиды slam и их использование | |
| BR112017009450A2 (pt) | ?produção de células bacterianas tindalizadas, intactas e imunologicamente ativas de lactobacillus rhamnosus gg (atcc 53103) e método para a determinação qualitativa e quantitativa das mesmas? |